Letermovir Tablet (240 mg, 480 mg)
Composition : Letermovir
Form: Tablet
Available Strength: 240 mg / 480 mg
Packing: Strip of 10 Tablet
Country Of Origin: India
Letermovir Brand Name:
Anvimo (Zydus Life Sciences)
Letermovir Tablets Supplier
Oddway International operates as a regulated letermovir tablets supplier, supporting institutional and trade-based sourcing of Letermovir for licensed healthcare and pharmaceutical buyers.
Letermovir is an antiviral pharmaceutical products supplied under regulated frameworks for clinical and institutional use. This product page provides formulation-level information relevant to procurement, documentation, and regulatory alignment.
Product Overview: Letermovir Tablets
Letermovir formulations are used in specialised clinical settings, particularly in transplant and hospital environments, where antiviral prophylaxis is required under physician-led protocols.
Letermovir is supplied within regulated pharmaceutical supply chains and are subject to manufacturer availability, regulatory approval, and destination-country import requirements.
Available Strengths and Formulations
(Subject to Regulatory Approval)
The following formulations are commonly referenced in institutional procurement and regulatory documentation.
| Formulation | Description |
|---|---|
| Letermovir 240 mg tablet | Oral tablet formulation used in regulated hospital and transplant protocols |
| Letermovir 480 mg tablet | Higher-strength oral tablet supplied for approved institutional use |
| Letermovir pellets | Alternative dosage form evaluated separately based on clinical need and regulatory acceptance |
Formulation availability may vary depending on manufacturer approvals and market-specific regulations.
Product Specifications
-
Dosage form: Tablet (pellets subject to regulatory scope)
-
Therapeutic category: Antiviral medicine
-
Use environment: Hospital and institutional settings
-
Supply basis: Regulated pharmaceutical supply frameworks
All specifications are provided for documentation and procurement alignment purposes.
Regulatory and Documentation Considerations
Supply of letermovir tablets is governed by pharmaceutical regulations applicable in both the exporting and importing jurisdictions. Product-level documentation may include:
-
Certificates of analysis
-
Manufacturing and quality certifications
-
Batch traceability records
-
Product specifications and labeling details
Documentation requirements vary by destination market and institutional procurement policies.
Supply to Institutions and Individuals
Letermovir is primarily supplied through institutional procurement channels. In specific clinical circumstances, supply to individual patients may be coordinated through regulated access mechanisms such as named patient or special access pathways, subject to medical justification and regulatory approval.
All supply activity is managed within structured pharmaceutical frameworks to ensure traceability, quality assurance, and regulatory oversight.
Summary
As a regulated letermovir tablets supplier, Oddway International supports compliant sourcing of Letermovir tablet formulations, including Letermovir 240 mg tablet, Letermovir 480 mg tablet, and, where applicable, Letermovir pellets, within institutional pharmaceutical supply frameworks.
This product page is intended to support documentation, procurement evaluation, and regulatory alignment for licensed healthcare buyers.
1 review for Letermovir Tablet (240 mg, 480 mg)
Shipping Options
We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.
Terms and Conditions
- Bulk Orders: You are responsible for any local import duties and taxes in your country.
- For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner's script or prescription is required.
- Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.
Frequently Asked Questions
Letermovir tablets are commonly referenced in institutional procurement documentation in strengths such as Letermovir 240 mg tablet and Letermovir 480 mg tablet, subject to manufacturer availability and regulatory acceptance.
Letermovir tablet formulations are typically used in hospital and specialised clinical settings, particularly within transplant and antiviral prophylaxis protocols under regulated healthcare frameworks.
In addition to tablet formulations, alternative dosage forms such as letermovir pellets may be evaluated separately, depending on clinical requirements, manufacturer availability, and regulatory approval.
Letermovir is generally procured by licensed pharmaceutical distributors, hospitals, transplant centres, and institutional healthcare organisations operating within regulated procurement systems.
Yes, In specific clinical circumstances, letermovir tablets can be supplied to individual patients through regulated access pathways such as named patient or special access mechanisms, subject to medical justification and regulatory approval.
Brown –
Received the delivery within the stipulated time to our clinic